Two Sigma Advisers
BFRI icon

Two Sigma Advisers’s Biofrontera BFRI Stock Holding History

Two Sigma Advisers’s Portfolio BFRI Stock Details BFRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-810
Closed -$30K – 2553
2022
Q2 		$30K Sell
810
-990
-55% -$60.1K ﹤0.01% 2519
2022
Q1 		$120K Buy
1,800
+870
+94% +$63.1K ﹤0.01% 2476
2021
Q4 		$140K Buy
+930
New +$102K ﹤0.01% 2368

Other funds holding BFRI

BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Two Sigma Advisers's BFRI Position: Q3 2022 in Review

Two Sigma Advisers sold out of Biofrontera (BFRI) in Q3 2022, closing a stake of 810 shares — an estimated $30K sold.

Two Sigma Advisers first reported a position in BFRI in Q4 2021 and held it in 3 quarters. The position peaked at $140K in Q4 2021. 16 funds tracked by Wall St. Rank hold BFRI as of Q3 2022.

  • Two Sigma Advisers reported no remaining Biofrontera position as of Q3 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 810 Biofrontera shares in Q3 2022, an estimated $30K.
  • Two Sigma Advisers first reported a position in Biofrontera in Q4 2021 and held it in 3 quarters.
  • Two Sigma Advisers's Biofrontera position peaked at $140K in Q4 2021.
  • 16 funds tracked by Wall St. Rank held Biofrontera as of Q3 2022.

Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.